262 related articles for article (PubMed ID: 12481826)
1. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
[TBL] [Abstract][Full Text] [Related]
2. Novel targets for the future development of antibacterial agents.
McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
J Appl Microbiol; 2002; 92 Suppl():28S-34S. PubMed ID: 12000610
[TBL] [Abstract][Full Text] [Related]
3. Delivering novel targets and antibiotics from genomics.
Payne DJ; Holmes DJ; Rosenberg M
Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
[TBL] [Abstract][Full Text] [Related]
4. The impact of genomics on novel antibacterial targets.
Payne DJ; Wallis NG; Gentry DR; Rosenberg M
Curr Opin Drug Discov Devel; 2000 Mar; 3(2):177-90. PubMed ID: 19649849
[TBL] [Abstract][Full Text] [Related]
5. Genomic approaches to antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
[TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
7. When will the genomics investment pay off for antibacterial discovery?
Mills SD
Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics in antibacterial drug discovery.
Freiberg C; Brötz-Oesterhelt H
Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
[TBL] [Abstract][Full Text] [Related]
9. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL
Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923
[TBL] [Abstract][Full Text] [Related]
10. Using genomics to develop novel antibacterial therapeutics.
Nagaraj NS; Singh OV
Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
[TBL] [Abstract][Full Text] [Related]
11. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
12. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae.
Lerner CG; Hajduk PJ; Wagner R; Wagenaar FL; Woodall C; Gu YG; Searle XB; Florjancic AS; Zhang T; Clark RF; Cooper CS; Mack JC; Yu L; Cai M; Betz SF; Chovan LE; McCall JO; Black-Schaefer CL; Kakavas SJ; Schurdak ME; Comess KM; Walter KA; Edalji R; Dorwin SA; Smith RA; Hebert EJ; Harlan JE; Metzger RE; Merta PJ; Baranowski JL; Coen ML; Thornewell SJ; Shivakumar AG; Saiki AY; Soni N; Bui M; Balli DJ; Sanders WJ; Nilius AM; Holzman TF; Fesik SW; Beutel BA
Chem Biol Drug Des; 2007 Jun; 69(6):395-404. PubMed ID: 17581233
[TBL] [Abstract][Full Text] [Related]
13. Use of genomics to select antibacterial targets.
Pucci MJ
Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
15. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.
Singh SB; Phillips JW; Wang J
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):160-6. PubMed ID: 17436551
[TBL] [Abstract][Full Text] [Related]
16. Emerging bacterial enzyme targets.
Su Z; Honek JF
Curr Opin Investig Drugs; 2007 Feb; 8(2):140-9. PubMed ID: 17328230
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial drug discovery and structure-based design.
Barker JJ
Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
[TBL] [Abstract][Full Text] [Related]
18. Crystallizing new approaches for antimicrobial drug discovery.
Schmid MB
Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
[TBL] [Abstract][Full Text] [Related]
19. Use of constraint-based modeling for the prediction and validation of antimicrobial targets.
Trawick JD; Schilling CH
Biochem Pharmacol; 2006 Mar; 71(7):1026-35. PubMed ID: 16329998
[TBL] [Abstract][Full Text] [Related]
20. Target-based drug discovery for the development of novel antiinfectives.
Selzer PM; Brutsche S; Wiesner P; Schmid P; Müllner H
Int J Med Microbiol; 2000 May; 290(2):191-201. PubMed ID: 11045924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
